NASDAQ:SAGE

Delisted

Sage Therapeutics Stock News

Healthcare > Biotechnology

Buy SAGE

*Your capital is at risk

$8.68

+0 (+0%)

At Close: Oct 30, 2025

The Schall Law Firm Is Conducting An Inquiry Into Sage Therapeutics Inc For Likely Securities Infringements And Invites Impacted Investors To Reach Out

11:00am, Saturday, 06'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Initiates Examination Into Sage Therapeutics Inc For Possible Securities Violations And Encourages Affected Investors To Establish Contact

04:00pm, Friday, 05'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Probes Sage Therapeutics Inc For Potential Securities Breaches And Urges Impacted Investors To Connect

12:15pm, Wednesday, 03'rd Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Violations Of Securities Laws And Investors Who Incurred Losses Are Encouraged To Reach Out

03:15pm, Tuesday, 02'nd Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Is Probing Sage Therapeutics Inc For Possible Breaches Of Securities Regulations And Urges Investors Who Endured Losses To Reach Out

05:00pm, Wednesday, 26'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Is Being Probed By The Schall Law Firm For Potential Securities Law Violations And Investors With Losses Are Encouraged To Reach Out

03:00pm, Tuesday, 25'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Law Breaches And Investors With Losses Are Urged To Connect

04:30pm, Monday, 24'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Investigates Sage Therapeutics Inc For Potential Violations Of Securities Laws And Encourages Investors Who Have Suffered Losses To Get In Touch

11:00am, Sunday, 23'rd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Probes Sage Therapeutics Inc For Possible Breaches Of Securities Laws And Invites Loss Suffering Investors To Connect With The Firm

11:00am, Saturday, 22'nd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Investigates Sage Therapeutics Inc For Potential Violations Of Securities Laws And Encourages Investors Who Have Suffered Losses To Get In Touch

05:00pm, Friday, 21'st Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Probes Sage Therapeutics Inc For Possible Breaches Of Securities Laws And Invites Loss Suffering Investors To Connect With The Firm

04:05pm, Thursday, 20'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Is Investigating Sage Therapeutics Inc For Potential Violations Of Securities Laws Investors With Losses Are Encouraged To Contact The Firm

04:05pm, Wednesday, 19'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Is Being Probed By The Schall Law Firm For Possible Securities Breaches Investors Who Have Suffered Losses Are Urged To Reach Out

05:45pm, Tuesday, 18'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc. Under Investigation By Schall Law Firm For Potential Securities Violations. Investors Who Lost Money Encouraged To Contact The Firm

07:15pm, Monday, 17'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

SAGE's Huntington's Disease Study Meets Primary Endpoint

11:46am, Wednesday, 12'th Jun 2024

The phase II SURVEYOR study evaluating SAGE's dalzanemdor as a potential treatment for patients with cognition dysfunction caused by Huntington's disease meets its primary endpoint.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by